GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Innovative Eyewear Inc (NAS:LUCY) » Definitions » Days Sales Outstanding

Innovative Eyewear (Innovative Eyewear) Days Sales Outstanding : 17.39 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Innovative Eyewear Days Sales Outstanding?

Innovative Eyewear's average Accounts Receivable for the three months ended in Mar. 2024 was $0.07 Mil. Innovative Eyewear's Revenue for the three months ended in Mar. 2024 was $0.38 Mil. Hence, Innovative Eyewear's Days Sales Outstanding for the three months ended in Mar. 2024 was 17.39.

The historical rank and industry rank for Innovative Eyewear's Days Sales Outstanding or its related term are showing as below:

LUCY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.71   Med: 32.16   Max: 42.31
Current: 27.97

During the past 5 years, Innovative Eyewear's highest Days Sales Outstanding was 42.31. The lowest was 22.71. And the median was 32.16.

LUCY's Days Sales Outstanding is ranked better than
91.75% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 64.88 vs LUCY: 27.97

Innovative Eyewear's Days Sales Outstanding declined from Mar. 2023 (74.89) to Mar. 2024 (17.39).


Innovative Eyewear Days Sales Outstanding Historical Data

The historical data trend for Innovative Eyewear's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Eyewear Days Sales Outstanding Chart

Innovative Eyewear Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
- - 22.71 42.31 32.16

Innovative Eyewear Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.89 69.51 53.23 16.37 17.39

Competitive Comparison of Innovative Eyewear's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Innovative Eyewear's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innovative Eyewear's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Innovative Eyewear's Days Sales Outstanding falls into.



Innovative Eyewear Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Innovative Eyewear's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.11 + 0.093) / 2 ) / 1.152*365
=0.1015 / 1.152*365
=32.16

Innovative Eyewear's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0.093 + 0.053) / 2 ) / 0.383*365 / 4
=0.073 / 0.383*365 / 4
=17.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innovative Eyewear  (NAS:LUCY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Innovative Eyewear Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Innovative Eyewear's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Eyewear (Innovative Eyewear) Business Description

Traded in Other Exchanges
N/A
Address
11900 Biscayne Boulevard, Suite 630, North Miami, FL, USA, 33138
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands-free.
Executives
Olivia C. Bartlett director 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
Louis Castro director 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
Konrad Dabrowski officer: Chief Financial Officer 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
Kristen Mclaughlin director 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
Harrison R. Gross director, officer: Chief Executive Officer 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33131
Frank Rescigna director 8101 BISCAYNE BLVD., SUITE 705, MIAMI FL 33138
Lucyd Ltd. 10 percent owner 11900 BISCAYNE BLVD., SUITE 630, MIAMI FL 33181
David Eric Cohen officer: Chief Technology Officer 11900 BISCAYNE BLVD., SUITE 705630, MIAMI FL 33131